Compumedics (ASX:CMP) FFO


ASX:CMP Compumedics Ltd ASX:CMP
61 GF Score
Price A$0.26
GF Value A$0.31
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Compumedics FFO?

FFO (Funds from operations) only applies to REITs.

ASX:CMP
61GF Score
Compumedics Ltd ASX:CMP
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Compumedics (ASX:CMP) Overvalued in 2026?

Based on GuruFocus' analysis, Compumedics stock appears to be undervalued. The current stock price of A$0.26 is trading 17.7% below its estimated GF Value™ of A$0.31. GuruFocus considers Compumedics to be Modestly Undervalued.

Key valuation signals for ASX:CMP:

  • FFO:
  • GF Value™: A$0.31 vs. price of A$0.26 (17.7% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the ASX:CMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Compumedics Business Description

Address 30-40 Flockhart Street, Abbotsford, Melbourne, VIC, AUS, 3067
Compumedics Ltd is a medical device company. It is engaged in the development, manufacturing, and commercialization of diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
61GF Score

Get the complete analysis for ASX:CMP

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.26
Price
A$0.31
GF Value